Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sight Sciences, Inc. - Common Stock (NQ:SGHT)

2.880 +0.100 (+3.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Sight Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
A Preview Of Sight Sciences's Earnings
Via Benzinga
Glaucoma Is The Second Leading Cause Of Blindness Globally – Skye Bioscience Appears To Be Making Rapid Progress In The Development Of Their Candidate To Treat It
Biomed company Skye Bioscience (OTCQB: SKYE) has seen positive results in its clinical research so far and is preparing for the next stage in the development of its therapy for eye disease.  
Via Benzinga
3 Prime Healthcare Takeover Targets
These three companies are attractive targets for their potential. 
Via The Motley Fool
Lions Gate Entertainment, DexCom, Yelp And Other Big Stocks Moving Higher On Friday
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 100 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
5 Analysts Have This to Say About Sight Sciences
Within the last quarter, Sight Sciences (NASDAQ:SGHT) has observed the following analyst ratings: 
Via Benzinga
Sight Sciences' Near-Term Upside Is Limited, Says This Analyst
Via Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process. 
Via Benzinga
Dow Rises Over 300 Points; US Adds 223,000 Jobs In December
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday. 
Via Benzinga
4 Analysts Have This to Say About Sight Sciences
Analysts have provided the following ratings for Sight Sciences (NASDAQ:SGHT) within the last quarter: 
Via Benzinga
Sight Sciences Posts Long-Term Safety, Effectiveness Data For Glaucoma Surgical System
Via Benzinga
Where Sight Sciences Stands With Analysts
  Sight Sciences (NASDAQ:SGHT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Sight Sciences: Q2 Earnings Insights
  Sight Sciences (NASDAQ:SGHT) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
Via Benzinga
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
Analyst Ratings for Sight Sciences
Analysts have provided the following ratings for Sight Sciences (NASDAQ:SGHT) within the last quarter: 
Via Benzinga
Skye Bioscience (OTCQB: SKYE) Heads Into 2023 As A Clinical-Stage Company After Dosing Its First Human Participants
This year has been quite busy for Skye Bioscience Inc. (OTCQB: SKYE). 
Via Benzinga
Unity Software, Amazon, Doximity And Other Big Gainers From Friday
U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
Dow Turns Higher; Nasdaq Jumps Over 200 Points
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 60 points on Friday. 
Via Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. 
Via Benzinga
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program. 
Via Benzinga
Nasdaq Surges 100 Points; Crude Oil Rises Sharply
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining 100 points on Friday. 
Via Benzinga
US Stocks Mixed Following Thursday's Rally; Dow Drops 50 Points
U.S. stocks traded mixed this morning on Friday, after the Dow Jones jumped 1,200 points in the previous session. 
Via Benzinga
Earnings Scheduled For November 10, 2022
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter. 
Via Benzinga
Morgan Stanley Maintains Overweight Rating for Sight Sciences: Here's What You Need To Know
Morgan Stanley has decided to maintain its Overweight rating of Sight Sciences (NASDAQ:SGHT) and lower its price target from $14.00 to $10.00. Shares of Sight Sciences are trading down 3.39% over the... 
Via Benzinga
Expert Ratings for Sight Sciences
Over the past 3 months, 4 analysts have published their opinion on Sight Sciences (NASDAQ:SGHT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Sight Sciences's Return On Capital Employed Insights
Sight Sciences (NASDAQ:SGHT) brought in sales totaling $17.23 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 2.49%, resulting in a loss of $23.84 million. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022
Upgrades 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.